Skip to main content
. Author manuscript; available in PMC: 2009 Aug 15.
Published in final edited form as: Cancer. 2008 Aug 15;113(4):690–700. doi: 10.1002/cncr.23700

Figure 2. Effects of Lanreotide on ERK1/2 phosphorylation.

Figure 2

Lanreotide phosphorylated ERK1/2 in NCI-H720 and KRJ-I cell lines (4A, 4C). Lanreotide had no effect on ERK1/2 phosphorylation in NCI-H727 (4B). The effects of lanreotide were inhibited by the MEK inhibitor, PD98059 (1μM) (4A–C). *p<0.01 vs. control; **p<0.05 vs. control; #p<0.05 vs. lanreotide. Mean±SEM; n=4.